We’re transforming the way the world treats inflammatory diseases by creating innovative, safe, and effective therapies that address both the symptoms and the root cause — improving lives and redefining what’s possible.

The Problem

The Problem

Millions of people worldwide struggle with debilitating inflammatory diseases. Existing biologic treatments often come with significant side effects and can be incredibly costly, limiting access for many patients.

Millions of people worldwide struggle with debilitating inflammatory diseases. Existing biologic treatments often come with significant side effects and can be incredibly costly, limiting access for many patients.

Bridging the Gap: Addressing the Challenges of Inflammatory Disease Treatment

Bridging the Gap: Addressing the Challenges of Inflammatory Disease Treatment

The Solution

Rādyx is pioneering a new approach to drug development. Unlike traditional single-molecule drugs, our polymolecular formulations target multiple mechanisms involved in complex diseases. Inspired by nature's wisdom, our polymolecular drugs offer a safer, more comprehensive solution to chronic conditions by addressing both symptoms and underlying causes.

the Challenges of Inflammatory Disease Treatment

Learn More

Partners in Innovation

Partners in Innovation

Seize the opportunity to invest in a company at the forefront of polymolecular drug development. Join us on our mission to revolutionize healthcare.

Invest in a brighter future

Invest in a brighter future

Join us

Join us

Freddie Ann Hoffman, MD

CDO

Stephen Morrissey, OMD

CEO/CSO

Staci J Eisner

CoO

Steve R Kishter, MD, DDS

CMO

Richard Samuelson, CFA

CfO

Jenny Morrissey, L.Ac

CHIEF OF STAFF

Freddie Ann Hoffman, MD

CDO

Jolene Anderson

Senior Advisor

Botanical medicine and product development leader with 30 years of experience.

Former FDA and Pfizer-Warner Lambert development leader.

Quality and regulatory leader in botanical manufacturing.

Clinical and medical development leader in complex therapeutics.

Finance executive and angel investor with multiple company exits.

Co-founder and botanical formulation developer with 30 years of experience.

Investor relations, diligence, and angel network strategist.

Our Team

CDO

Freddie Ann Hoffman, MD

Freddie Ann Hoffman, MD

Freddie Ann Hoffman, MD

CoO

Staci J Eisner

Staci J Eisner

Senior Advisor

Jolene Anderson

Jolene Anderson

Jolene Anderson

Jolene Anderson

CEO/CSO

Stephen Morrissey, OMD

Stephen Morrissey, OMD

CMO

Steve R Kishter, MD, DDS

Steve R Kishter, MD, DDS

CfO

Richard Samuelson, CFA

Richard Samuelson, CFA

CHIEF OF STAFF

Jenny Morrissey, L.Ac

Jenny Morrissey, L.Ac

Jenny Morrissey, L.Ac.

Our Team